Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

JSPR

Jasper Therapeutics (JSPR)

Jasper Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:JSPR
FechaHoraFuenteTítuloSímboloCompañía
05/03/202415:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:JSPRJasper Therapeutics Inc
05/03/202415:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:JSPRJasper Therapeutics Inc
04/03/202406:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JSPRJasper Therapeutics Inc
20/02/202418:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JSPRJasper Therapeutics Inc
09/02/202419:36Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:JSPRJasper Therapeutics Inc
02/02/202408:50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:JSPRJasper Therapeutics Inc
20/11/202316:11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JSPRJasper Therapeutics Inc
09/11/202315:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JSPRJasper Therapeutics Inc
09/11/202308:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JSPRJasper Therapeutics Inc
21/06/202305:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:JSPRJasper Therapeutics Inc
21/06/202305:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JSPRJasper Therapeutics Inc
20/06/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JSPRJasper Therapeutics Inc
28/04/202315:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:JSPRJasper Therapeutics Inc
21/04/202315:06Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:JSPRJasper Therapeutics Inc
21/04/202315:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:JSPRJasper Therapeutics Inc
21/04/202315:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:JSPRJasper Therapeutics Inc
14/04/202315:26Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:JSPRJasper Therapeutics Inc
08/03/202315:47Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:JSPRJasper Therapeutics Inc
08/03/202315:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JSPRJasper Therapeutics Inc
27/02/202315:06Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:JSPRJasper Therapeutics Inc
14/02/202307:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JSPRJasper Therapeutics Inc
06/02/202315:44Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JSPRJasper Therapeutics Inc
31/01/202315:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:JSPRJasper Therapeutics Inc
25/01/202315:42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:JSPRJasper Therapeutics Inc
10/11/202215:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:JSPRJasper Therapeutics Inc
19/10/202205:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:JSPRJasper Therapeutics Inc
07/10/202215:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:JSPRJasper Therapeutics Inc
12/08/202215:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:JSPRJasper Therapeutics Inc
13/07/202207:32TipRanksCredit Suisse Thinks Jasper Therapeutics’ Stock is Going to RecoverNASDAQ:JSPRJasper Therapeutics Inc
13/05/202207:39TipRanksJasper Therapeutics (JSPR) Gets a Buy Rating from Credit SuisseNASDAQ:JSPRJasper Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:JSPR